Estimating the Future Health and Social Care Costs of Alzheimer's Disease Dementia in the UK: Impact of Disease Modifying Therapy Efficacy, Uptake, and Care Model – A Scenario Modelling Study
Potential cost offset from DMT are large but highly dependent on the model of healthcare delivery and the ability of healthcare systems to scale up diagnosis and treatment services.
Authors
- M. Evans
- Benjamin Bray (ORCID: https://orcid.org/0000-0002-8983-7530)
- Milana Ivkovic
- Simon Edwards (ORCID: https://orcid.org/0000-0002-3831-211X)
- Christian Ahmad Wichmann
- Mei Sum Chan
- Jamie Kettle
- Alice Clark
- Dominic Trepel
- Craig Ritchie
- Julie Hviid Hahn‐Pedersen
Institutions
- University of St Andrews (GB)
- Novo Nordisk (Denmark) (DK)
- Trinity College (CA)
- Trinity College Dublin (IE)
- Central and North West London NHS Foundation Trust (GB)
- Peacocks Medical Group (United Kingdom) (GB)
- Scottish Water (United Kingdom) (GB)
- University Hospital Llandough (GB)
Publication Details
- Journal
- International Journal of Geriatric Psychiatry
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/gps.70185
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00